Ambiguous coronary angiography: clinical utility of intravascular ultrasound.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMID 1617711)

Published in Cathet Cardiovasc Diagn on July 01, 1992

Authors

C J White1, S R Ramee, T J Collins, A Jain, J E Mesa

Author Affiliations

1: Department of Medicine, Ochsner Medical Institutions, New Orleans, Louisiana 70121.

Articles citing this

Intracoronary ultrasound: current state of the art. Br Heart J (1995) 0.88

Enough with the fantastic voyage: will IVUS pay in Peoria? Cathet Cardiovasc Diagn (1992) 0.75

Do we have enough evidence to insist we have IVUS? Heart (1997) 0.75

Articles by these authors

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Kidney transplantation under FK 506. JAMA (1990) 7.45

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01

Implementation of a high-sensitivity Micro-Angiographic Fluoroscope (HS-MAF) for in-vivo endovascular image guided interventions (EIGI) and region-of-interest computed tomography (ROI-CT). Proc SPIE Int Soc Opt Eng (2008) 3.49

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

Designing Endocrine Disruption Out of the Next Generation of Chemicals. Green Chem (2013) 2.47

Maternal feeding practices and beliefs and their relationships to overweight in early childhood. J Dev Behav Pediatr (2001) 2.39

The effects of FK 506 on renal function after liver transplantation. Transplant Proc (1990) 2.31

Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc (1991) 2.26

Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res (2001) 2.22

A comparison of fluorescent Ca2+ indicator properties and their use in measuring elementary and global Ca2+ signals. Cell Calcium (2000) 2.21

Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J (2002) 2.19

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology (1999) 2.15

Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study. Int J Clin Pract (2011) 2.12

One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10

Calcium signalling--an overview. Semin Cell Dev Biol (2001) 2.06

Reduction in radiation exposure during coronary angiography. Cathet Cardiovasc Diagn (1990) 2.03

Multicenter trial of the wallstent in the iliac and femoral arteries. J Vasc Interv Radiol (1997) 1.98

Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet (1995) 1.96

BCL-6 expression during B-cell activation. Blood (1996) 1.95

Sensitivity of meningococci to sodium sulphadiazine and six antibiotics. J Med Microbiol (1970) 1.83

Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc (1991) 1.75

Investigating the thyroid nodule. BMJ (2009) 1.73

The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71

Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc (1991) 1.69

The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc (1991) 1.60

Accuracy and applicability of the revised WHO classification (2009) of dengue in children seen at a tertiary healthcare facility in northern India. Infection (2013) 1.59

Oral glucose tolerance test in liver recipients treated with FK 506. Transplant Proc (1990) 1.56

Vertebral artery stenting. Catheter Cardiovasc Interv (2001) 1.55

Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation (1992) 1.53

Concurrent dengue virus and Japanese encephalitis virus infection of the brain: is it co-infection or co-detection? Infection (2012) 1.52

Polymerase chain reaction vs. conventional diagnosis in fine needle aspirates of tuberculous lymph nodes. Acta Cytol (2001) 1.51

An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48

A new balloon-expandable tantalum coil stent: angiographic patency and histologic findings in an atherogenic swine model. J Am Coll Cardiol (1992) 1.48

Bacteriology of neonatal septicaemia in a tertiary care hospital of northern India. Indian J Med Microbiol (2007) 1.48

Converted laparoscopic colorectal surgery. Surg Endosc (2001) 1.48

Percutaneous bailout therapy of a perforated vein graft using a stent-autologous vein patch. Cathet Cardiovasc Diagn (1996) 1.47

Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45

Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: immediate results and six-month follow-up of the multicenter AngioJet registry. Possis Peripheral AngioJet Study AngioJet Investigators. Cathet Cardiovasc Diagn (1998) 1.45

Coronary artery fistula related to dilatation of totally occluded vessel. Clin Cardiol (1993) 1.44

Infrapopliteal drug-eluting stents for chronic limb ischemia. Catheter Cardiovasc Interv (2008) 1.43

Glutathione is required for intestinal function. Proc Natl Acad Sci U S A (1990) 1.43

Transversus abdominis plane block using the loss of resistance to air technique. Minerva Anestesiol (2012) 1.43

Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. Proc Natl Acad Sci U S A (1991) 1.43

Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique. Clin Oncol (R Coll Radiol) (2002) 1.42

Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41

Treatment of new pulmonary tuberculosis patients: what do allopathic doctors do in India? Int J Tuberc Lung Dis (2002) 1.40

Mandibular nerve block for peri-operative pain relief using a peripheral nerve stimulator. Anaesthesia (2012) 1.40

Methotrexate for rheumatoid arthritis. J Assoc Physicians India (1994) 1.39

Administration of an alginate based gastric reflux suppressant on the bioavailability of omeprazole. Indian J Med Res (2006) 1.39

Recanalization of arterial occlusions with a lensed fiber and a holmium:YAG laser. Lasers Surg Med (1991) 1.39

Induction of ventricular tachycardia in patients with left ventricular aneurysms and no history of arrhythmia. Am J Cardiol (1988) 1.39

Hypokalaemia mimicking Guillain-Barre syndrome. J Assoc Physicians India (1989) 1.39

Gallbladder carcinoma: experience of 116 cases. Trop Gastroenterol (2000) 1.39

Initial results of peripheral vascular angioplasty performed by experienced interventional cardiologists. Am J Cardiol (1992) 1.39

High-speed rotational ablation (Rotablator) for unfavorable lesions in peripheral arteries. Cathet Cardiovasc Diagn (1993) 1.38

Thoracic epidural catheterization leading to delayed transient neurological symptoms with normal imaging findings. Acta Anaesthesiol Scand (2008) 1.38

Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage. Proc Natl Acad Sci U S A (1989) 1.37

FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37

Neurologic complications of FK 506. Transplant Proc (1991) 1.34

Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg (1994) 1.33

Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther (2009) 1.32

Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol (1996) 1.30

Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc (1990) 1.30

De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl (2001) 1.30

Pharmacokinetics of FK 506 in transplant patients. Transplant Proc (1991) 1.30

Prevalence of dental caries and treatment needs in the school-going children of rural areas in Udaipur district. J Indian Soc Pedod Prev Dent (2007) 1.29

Coronary artery fistula: an abnormality affecting all age groups. Medicine (Baltimore) (1990) 1.27

Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant (2006) 1.26

Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clin Pharmacol Ther (2010) 1.26

Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSciTech (2009) 1.25

An analysis of time utilization and cancellations of scheduled cases in the main operation theater complex of a tertiary care teaching institute of North India. J Postgrad Med (2014) 1.24

An immunologically active arabinogalactan from Tinospora cordifolia. Phytochemistry (1999) 1.22

Immunopathological study of spleen during Japanese encephalitis virus infection in mice. Br J Exp Pathol (1988) 1.22

Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet (2000) 1.22

The initiator element: a paradigm for core promoter heterogeneity within metazoan protein-coding genes. Cold Spring Harb Symp Quant Biol (1998) 1.21

Glutathione metabolism in the lung: inhibition of its synthesis leads to lamellar body and mitochondrial defects. Proc Natl Acad Sci U S A (1989) 1.21

Mechanism of synergy between TATA and initiator: synergistic binding of TFIID following a putative TFIIA-induced isomerization. Genes Dev (1997) 1.21

Prevalence of gingival diseases, malocclusion and fluorosis in school-going children of rural areas in Udaipur district. J Indian Soc Pedod Prev Dent (2007) 1.21

The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. Eur J Epidemiol (2000) 1.18

Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc (1993) 1.18

Occurrence of overlooked zoonotic tuberculosis: detection of Mycobacterium bovis in human cerebrospinal fluid. J Clin Microbiol (2006) 1.17

Socioeconomic gradient in old age mortality in Wuhan, China. J Gerontol B Psychol Sci Soc Sci (2000) 1.17

Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes. Diabetes Care (1998) 1.16